SEC Form 4 · accession 0000899243-16-024118
Celator Pharmaceuticals Inc · CPXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred M Powell
Officer — VP and Chief Financial Officer
Period of report
Jun 29, 2016
Accepted (ET)
Jul 1, 2016 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001327467
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2016 | G | 1,665 | $0.00 | D | 84,177 | D |
Table II — derivative securities
No Table II lines on this filing.